CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | Higa Tomohiro SVP, Finance | Sale | −717 | $1.25 | $898 | 97,060 |
| 2025-08-18 | Higa Tomohiro SVP, Finance | Sale | −1,722 | $1.25 | $2K | 95,338 |
| 2025-05-29 | Stehman-Breen Catherine Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Walsh Jeffrey T. Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Burroughs Amy L. Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | GOEDDEL DAVID V Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Williams R Sanders Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Srivastava Deepak Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Lee June Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-29 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to buy) | +107,400 | 107,400 | ||
| 2025-05-16 | Higa Tomohiro SVP, Finance | Sale | −1,390 | $0.44 | $615 | 98,300 |
| 2025-05-16 | Tingley Whittemore Chief Medical Officer | Sale | −2,937 | $0.44 | $1K | 171,856 |
| 2025-05-16 | Ali Faraz Chief Executive Officer | Sale | −3,189 | $0.44 | $1K | 317,325 |
| 2025-03-10 | Higa Tomohiro SVP, Finance | Sale | −1,017 | $0.54 | $548 | 101,155 |
| 2025-03-10 | Higa Tomohiro SVP, Finance | Sale | −620 | $0.54 | $334 | 100,535 |
| 2025-03-10 | Higa Tomohiro SVP, Finance | Sale | −845 | $0.54 | $455 | 99,690 |
| 2025-03-10 | Tingley Whittemore Chief Medical Officer | Sale | −1,727 | $0.54 | $930 | 180,464 |
| 2025-03-10 | Tingley Whittemore Chief Medical Officer | Sale | −4,073 | $0.54 | $2K | 176,391 |
| 2025-03-10 | Tingley Whittemore Chief Medical Officer | Sale | −1,598 | $0.54 | $860 | 174,793 |
| 2025-03-10 | Ali Faraz Chief Executive Officer | Sale | −5,794 | $0.54 | $3K | 324,461 |
Page 4 of 12 · 228 trades